Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06586671
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
A Study to Compare Forms of Nemtabrutinib MK-1026 in Healthy Adult Participants MK-1026-007
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Open-Label Two-Part Two-Period Crossover Study to Determine Bioequivalence Between Nemtabrutinib FFP and FMF2 Formulations FMF1 and FMF2 Formulations at 65 mg Single Dose in Healthy Male Participants
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the study is to measure and compare the levels of nemtabrutinib in the blood after taking different forms of nemtabrutinib orally on an empty stomach fasted to see if they are the same or different
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None